How many insider trades does FilingIQ track for INTS?

FilingIQ tracks 6 Form 4 insider transactions for INTS (INTENSITY THERAPEUTICS, INC.), covering filings from Jun 5, 2024 onwards. 1 of those were filed in the last 90 days.

Are INTS insiders net buyers or net sellers?

Across the full Form 4 history for INTS, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does INTS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is INTS in?

INTENSITY THERAPEUTICS, INC. (INTS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $15.28M.

INTS insider trading

NasdaqCM Healthcare

INTENSITY THERAPEUTICS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$15.28M

About INTENSITY THERAPEUTICS, INC.

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Company website: www.intensitytherapeutics.com

INTS insider activity at a glance

FilingIQ has scored 6 insider transactions for INTS since Jun 5, 2024. The most recent filing in our index is dated Mar 26, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live INTS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for INTS?: FilingIQ tracks 6 Form 4 insider transactions for INTS (INTENSITY THERAPEUTICS, INC.), covering filings from Jun 5, 2024 onwards. 1 of those were filed in the last 90 days.
Are INTS insiders net buyers or net sellers?: Across the full Form 4 history for INTS, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does INTS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is INTS in?: INTENSITY THERAPEUTICS, INC. (INTS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $15.28M.

Methodology & sources

Every INTS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.